Literature DB >> 6161885

Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

G Camussi, M Aglietta, R Coda, F Bussolino, W Piacibello, C Tetta.   

Abstract

The origin of platelet activating factor (PAF) from human leucocytes was investigated. Purified monocytes release PAF passively at pH 10.6, when challenged with Ionophore A 23187 or under phagocytic stimuli. Pure preparations of polymorphonuclear neutrophils liberate PAF passively, when challenged with C5a, neutrophil cationic proteins (CP), their carboxypeptidase B derived products (C5a des Arg, CP des Arg) or under phagocytic stimuli. Basophil rich buffy coat cells release PAF when challenged with C5a, CP, anti-IgE (in low amount) or Synacthen concomitantly with basophil degranulation and histamine release. Electron microscopy studies, carried out on Synacthen-stimulated basophil rich buffy coat, provide morphological evidence for platelet-basophil interaction. In conclusion our data demonstrate that PAF can be released from different leucocyte populations. However, the stimuli able to trigger such release appear to have some specificity for the cell target.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161885      PMCID: PMC1458080     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The role of platelet-activating factor in platelet aggregation.

Authors:  M Chignard; J P Le Couedic; M Tence; B B Vargaftig; J Benveniste
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

3.  Human neutrophil-derived platelet activating factor.

Authors:  G Z Lotner; J M Lynch; S J Betz; P M Henson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

4.  Continuous automatic fluorometric evaluation of total blood histamine.

Authors:  F Ruff; A Saindelle; E Dutripon; J L Parrot
Journal:  Nature       Date:  1967-04-15       Impact factor: 49.962

5.  [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].

Authors:  J Benveniste; M Tencé; P Varenne; J Bidault; C Boullet; J Polonsky
Journal:  C R Seances Acad Sci D       Date:  1979-11-26

6.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

7.  The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.

Authors:  J O Shaw; P M Henson
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

8.  Immunological mechanisms of human platelet involvement.

Authors:  G Camussi; C Tetta; G Segoloni; A Vercellone
Journal:  Ric Clin Lab       Date:  1978 Oct-Dec

9.  Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes.

Authors:  J M Mencia-Huerta; J Benveniste
Journal:  Eur J Immunol       Date:  1979-05       Impact factor: 5.532

10.  Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP.

Authors:  F Bussolino; J Benveniste
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

View more
  53 in total

Review 1.  The pulmonary physician and critical care. 4. A new look at the pulmonary circulation in acute lung injury.

Authors:  G A Fox; D G McCormack
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Platelet-activating factor relaxes ferret tracheal smooth muscle and reduces transepithelial potential difference in vitro.

Authors:  S E Webber; T Morikawa; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.

Authors:  G Montrucchio; G Alloatti; F Mariano; R de Paulis; A Comino; G Emanuelli; G Camussi
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

5.  Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis.

Authors:  Eldad A Hod; Set A Sokol; James C Zimring; Steven L Spitalnik
Journal:  Int J Clin Exp Pathol       Date:  2008-05-30

6.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Intracellular platelet-activating factor regulates eicosanoid generation in guinea-pig resident peritoneal macrophages.

Authors:  A G Stewart; W A Phillips
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

8.  Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).

Authors:  G Camussi; C Tetta; G Segoloni; M Chiara Deregibus; F Bussolino
Journal:  Agents Actions       Date:  1981-12

9.  1-O-alkyl-2-acetyl-sn-glycerol: a platelet-activating factor metabolite with biological activity in vascular smooth muscle cells.

Authors:  L L Stoll; P H Figard; N R Yerram; M A Yorek; A A Spector
Journal:  Cell Regul       Date:  1989-11

10.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.